Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Moaz O. Moursi, Haya Salem, Ayman R. Ibrahim, Sandy Marzouk, Sara Al-Meraghi, Maha Al-Ajmi, Alreem Al-Naimi & Lolwa Alansari. (2023) The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome. Gynecological Endocrinology 39:1.
Read now
Read now
Renae C Fernandez, Vivienne M Moore, Emer M Van Ryswyk, Tamara J Varcoe, Raymond J Rodgers, Wendy A March, Lisa J Moran, Jodie C Avery, R Doug McEvoy & Michael J Davies. (2018) Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nature and Science of Sleep 10, pages 45-64.
Read now
Read now
Krzysztof C. Lewandowski, Danuta Gasior-Perczak, Aldona Kowalska & Andrzej Lewinski. (2014) Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas. Gynecological Endocrinology 30:5, pages 385-387.
Read now
Read now
Hung-wen Su, Ching-min Chen, Szu-yuan Chou, So-jung Liang, Chun-sen Hsu & Ming-i Hsu. (2011) Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia. Gynecological Endocrinology 27:1, pages 55-62.
Read now
Read now
Articles from other publishers (35)
A.B.M. Kamrul-Hasan & Fatema Tuz Zahura Aalpona. (2024) Metabolic association of serum prolactin in polycystic ovary syndrome: A retrospective analysis of 840 patients in Bangladesh. Endocrine and Metabolic Science 14, pages 100153.
Crossref
Crossref
Lara Mastnak, Rok Herman, Simona Ferjan, Andrej Janež & Mojca Jensterle. (2023) Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects. Life 13:11, pages 2124.
Crossref
Crossref
Sezin ERTÜRK AKSAKAL, Ramazan Erda PAY, İrem Özge UZUNOĞLU MEHRASA, Burcu TİMUR, Gülay BALKAŞ & Yaprak ENGİN ÜSTÜN. (2023) Comparison of Clinical and Biochemical Parameters in Adolescent and Adult Patients with Polycyctic Ovary Syndrome. Forbes Journal of Medicine 4:1, pages 51-56.
Crossref
Crossref
Fatemeh Mahboobifard, Maryam Rahmati, Mina Amiri, Fereidoun Azizi & Fahimeh Ramezani Tehrani. (2022) To what extent does polycystic ovary syndrome influence the cut-off value of prolactin? Findings of a community-based study. Advances in Medical Sciences 67:1, pages 79-86.
Crossref
Crossref
WaliuOlatunbosun Oladosu, OlanrewajuSaheed Jimoh, WasiuAdebisi Adeniyi, AdewaleMukaila Alayo, AminatOlayinka Ahmed, SekinatTitilayo Raji-Olarinoye, TaofeeqAbiodun Ajadi & SikiruAbayomi Biliaminu. (2022) Pattern of common hormonal disorders among patients with polycystic ovarian syndrome at a tertiary health facility in Nigeria. Nigerian Journal of Medicine 31:1, pages 92.
Crossref
Crossref
Philippe Chanson & Dominique Maiter. 2022. The Pituitary. The Pituitary
495
543
.
Sara Abou Sherif, Rebecca Newman, Sara Haboosh, Ahmed Al‐Sharefi, Nikoleta Papanikolaou, Anastasia Dimakopoulou, Lisa J. Webber, Ali Abbara, Stephen Franks, Waljit S. Dhillo & Channa N. Jayasena. (2021) Investigating the potential of clinical and biochemical markers to differentiate between functional hypothalamic amenorrhoea and polycystic ovarian syndrome: A retrospective observational study. Clinical Endocrinology 95:4, pages 618-627.
Crossref
Crossref
John Ayuk. 2021. Assisted Reproduction Techniques. Assisted Reproduction Techniques
89
95
.
Robert L. Rosenfield, David W. Cooke & Sally Radovick. 2021. Sperling Pediatric Endocrinology. Sperling Pediatric Endocrinology
528
626
.
Irene Samperi, Kirstie Lithgow & Niki Karavitaki. (2019) Hyperprolactinaemia. Journal of Clinical Medicine 8:12, pages 2203.
Crossref
Crossref
Fahimeh Ramezani Tehrani & Mina Amiri. (2019) Polycystic Ovary Syndrome in Adolescents: Challenges in Diagnosis and Treatment. International Journal of Endocrinology and Metabolism 17:3.
Crossref
Crossref
Philippe Chanson & Dominique Maiter. (2019) The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Practice & Research Clinical Endocrinology & Metabolism 33:2, pages 101290.
Crossref
Crossref
Clémence Delcour, Geoffroy Robin, Jacques Young & Didier Dewailly. (2019) PCOS and Hyperprolactinemia: what do we know in 2019?. Clinical Medicine Insights: Reproductive Health 13, pages 117955811987192.
Crossref
Crossref
Lucio Vilar, Clarice Freitas Vilar, Ruy Lyra & Maria da Conceição Freitas. (2019) Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia. Neuroendocrinology 109:1, pages 7-19.
Crossref
Crossref
Julie A. Irving & Philip B. Clement. 2019. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
715
770
.
Rocío Villar Taibo, Mildred Sifontes Dubon, Ignacio Bernabeu Morón & Felipe F. Casanueva. 2019. Prolactin Disorders. Prolactin Disorders
95
110
.
Eleni Magdalini Kyritsi, Georgios K. Dimitriadis, Anna Angelousi, Hiten Mehta, Amjad Shad, Maria Mytilinaiou, Gregory Kaltsas & Harpal S. Randeva. (2018) The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome. European Journal of Clinical Investigation 48:7, pages e12961.
Crossref
Crossref
Julie A. Irving & Philip B. Clement. 2018. Blaustein's Pathology of the Female Genital Tract. Blaustein's Pathology of the Female Genital Tract
1
56
.
Shuxia Li, Dongyi Zhu, Hongmei Duan, Anran Ren, Dorte Glintborg, Marianne Andersen, Vibe Skov, Mads Thomassen, Torben Kruse & Qihua Tan. (2016) Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women. Oncotarget 8:13, pages 20656-20666.
Crossref
Crossref
Philippe Chanson & Dominique Maiter. 2017. The Pituitary. The Pituitary
467
514
.
Nadine Binart. 2017. The Pituitary. The Pituitary
129
161
.
Özgür Yilmaz, Mehmet Calan, Tuncay Kume, Muzaffer Temur, Pınar Yesil & Mehmet Y. Senses. (2015) The effect of prolactin levels on MPV in women with PCOS. Clinical Endocrinology 82:5, pages 747-752.
Crossref
Crossref
Selma F. Witchel, Sharon Oberfield, Robert L. Rosenfield, Ethel Codner, Andrea Bonny, Lourdes Ibáñez, Alexia Pena, Reiko Horikawa, Veronica Gomez-Lobo, Dipesalema Joel, Hala Tfayli, Silva Arslanian, Preeti Dabadghao, Cecilia Garcia Rudaz & Peter A. Lee. (2015) The Diagnosis of Polycystic Ovary Syndrome during Adolescence. Hormone Research in Paediatrics 83:6, pages 376-389.
Crossref
Crossref
. (2014) Letrozole or Clomiphene for Infertility in the Polycystic Ovary Syndrome. New England Journal of Medicine 371:15, pages 1462-1464.
Crossref
Crossref
D. Glintborg, M. Altinok, H. Mumm, K. Buch, P. Ravn & M. Andersen. (2014) Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome. Human Reproduction 29:8, pages 1773-1779.
Crossref
Crossref
Lucio Vilar, Maria Fleseriu & Marcello D. Bronstein. (2014) Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arquivos Brasileiros de Endocrinologia & Metabologia 58:1, pages 9-22.
Crossref
Crossref
Martijn J.J. Finken, Bart Boersma & Joost Rotteveel. (2013) Hyperprolactinemia and hyperandrogenism in an adolescent girl presenting with primary amenorrhea. European Journal of Obstetrics & Gynecology and Reproductive Biology 166:2, pages 230-231.
Crossref
Crossref
Uttara Saran, Frank Arfuso, Nikolajs Zeps & Arunasalam Dharmarajan. (2012) Secreted frizzled-related protein 4 expression is positively associated with responsiveness to Cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers. BMC Cell Biology 13:1.
Crossref
Crossref
John Ayuk. 2012. Assisted Reproduction Techniques. Assisted Reproduction Techniques
56
60
.
Lori D. Hill, Kathryn G. Ewens, Brion S. Maher, Timothy P. York, Richard S. Legro, Andrea Dunaif & Jerome F. StraussIIIIII. (2012) Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Molecular and Cellular Endocrinology 350:1, pages 72-77.
Crossref
Crossref
Geoffroy Robin, Sophie Catteau-Jonard, Jacques Young & Didier Dewailly. (2011) Lien physiopathologique entre syndrome des ovaires polymicrokystiques et hyperprolactinémie : mythe ou réalité ?. Gynécologie Obstétrique & Fertilité 39:3, pages 141-145.
Crossref
Crossref
Mary P. Gillam & Mark E. Molitch. 2011. The Pituitary. The Pituitary
119
166
.
Julie A. Irving & Philip B. Clement. 2011. Blaustein’s Pathology of the Female Genital Tract. Blaustein’s Pathology of the Female Genital Tract
579
624
.
Ban H. Khalaf. (2010) Leptin levels in relation to marital status and neuroendocrine function in Iraqi females with polycystic ovary syndrome. Saudi Pharmaceutical Journal 18:1, pages 41-44.
Crossref
Crossref
Jaspreet Chahal & Janet Schlechte. (2008) Hyperprolactinemia. Pituitary 11:2, pages 141-146.
Crossref
Crossref